Discover the Latest Advances in Variant Classification and Interpretation Tools at Golden Helix's Booth at ESHG 2024
Join Golden Helix at the European Human Genetics (ESHG) 2024 conference and discover the latest advances in genetic research. This premier event brings together leading researchers, clinicians, and industry experts to share their insights on cutting-edge topics in medical genetics.
At Golden Helix's booth, you'll have the opportunity to learn more about our advanced genetic analysis tools. Our comprehensive suite of software solutions includes VarSeq, VS-CNV, VSClinical, VSPipeline, and VSWarehouse, which provide powerful and user-friendly options for genomic analysis and interpretation based on the ACMG and AMP Guidelines. We will also be offering demos on our latest pharmacogenomics solution, VSPGx.
Stop by our booth to see a live demo of our software, learn about the latest features, and discuss how our tools can enhance your genetic research. Plus, by visiting our booth for a demo, you'll receive one of our famous t-shirts.
Don't miss this chance to discover the latest in genetic analysis tools and meet with our expert team at ESHG 2024. We look forward to seeing you there!
Find us in Booth #428
Come check out our exciting product demos and meet with our team to discuss your needs in Booth #1313. Plus, don't miss the chance to score brand new t-shirts designed exclusively for ESHG demo attendees! See you there!
Demo schedule
Coming Soon!
Exhibitor Talk
Golden Helix - A Clinical Interpretation Solution for Next Generation Sequencing Labs
Monday, June 3, 12:00 - 13:00, Room: New York 1
Presented by: Dr. Andreas Scherer, President and CEO & Nathan Fortier, PhD, Golden Helix Director of Research
Guest Speaker: Tina Han, Twist Biosciences
Join us for an insightful discussion on our latest advancements in the clinical interpretation of next-generation sequencing data. Discover our high quality variant analysis and interpretation capabilities that scale efficiently. Implement ACMG and AMP guidelines for variant interpretation, directly call CNVs in target regions, exomes and whole genomes, and utilize repeatable clinical interpretation workflows. Recently, we unveiled our pharmacogenomics solution VSPGx, based on the CPIC guidelines. We will share some of the VSPGx capabilities in further detail.